from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0761c/adhB

LFCtreatmentdescriptionclass of inhibitor

0.371

Amikacinug/mL Amikacintranslation

-0.158

Cap5-10ug/mL Capreomycintranslation

-0.031

Rox10-50 ug/mL Roxithromycintranslation

0.754

SM2-5 ug/mL Streptomycintranslation

0.075

Tet5-10 ug/mL Tetracyclinetranslation

-1.672

Rif0.2-5ug/mL Rifampicintranscription

-1.324

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.431

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.169

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.604

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.451

Clofazimine10-13 ug/mL Clofaziminerespiration

0.882

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.994

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.594

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.460

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.719

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.025

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.843

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.005

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.171

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.450

KCN5-20 ug/mL Potassium cyaniderespiration

0.061

NaN30.2-2 mM Sodium aziderespiration

0.327

Nigericin50 uM Nigericinrespiration

-1.246

TRC10-150 ug/mL Triclosanrespiration

-1.660

TRZ10-25 ug/mL Thioridazinerespiration

-0.935

Valinomycin0.5-10 uM Valinomycinrespiration

0.788

ZnSO42 mM ZnSO4respiration

-0.426

menadione6-10 ug/mL Menadionerespiration

-0.188

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.616

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.040

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.614

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.056

NRP_1Non-replicating persistence stage 1dosRassociated

0.846

Amp0.2mg/mL AmpicillincellWall

0.742

Cephalexin20-100 ug/mL CephalexincellWall

0.658

Cerulenin0.32-5 ug/mL CerulenincellWall

1.165

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.498

EMB10-20 ug/mL EthambutolcellWall

0.703

Eta12-40 ug/mL EthionamidecellWall

0.454

INH0.2-0.4 ug/mL IsoniazidcellWall

0.383

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.503

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.582

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.285

BZA0.12 mg/mL BenzamidearomaticAmides

-0.050

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.313

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.080

H2O24 mM hydrogen peroxideDNAdamaging

-0.489

Levo10 ug/mL LevofloxacinDNAdamaging

0.563

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.165

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.840

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.586

UVUV-irradiationDNAdamaging

-0.972

ARP41-4 ug/mL Antitubercular compound ARP4?

0.905

Antimycin12.5-50 ug/mL Antimycin A?

0.412

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.718

PA_110-50 ug/mL Antitubercular compound PA-1?

1.245

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.832

PA8240.2-2 ug/mL PA-824?

-0.901

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.057

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.356

Verapamil50 uM Verapamil?

0.067

mercaptoethanol2 mM 2-Mercaptoethanol?

0.609

methoxatin10-20 ug/mL Methoxatin?